An association study between catalase -262C>T gene polymorphism, sodium-lithium countertrasport activity, insulin resistance, blood lipid parameters and their response to atorvastatin, in Greek dyslipidaemic patients and normolipidaemic controls

References

• West IC, Rutherford PA, Thomas TH. Sodium-lithium countertransport: physiology and function. J Hypertens 1998; 16: 3–13
   Google Scholar
• Morisson AC, Boerwinkle E, Turner ST, Ferrell RE. Regional association-based fine-mapping for sodium-lithium countertransport on chromosome 10. Am J Hypertens 2008; 21: 117–121
   Google Scholar
• Mead P, Wilkinson R, Thomas TH. Thiol protein defect in sodium-lithium countertransport in subset of essential hypertension. Hypertension 1999; 34: 1275–1280
   Google Scholar
• Wierzbicki AS, Hardman TC, Cheung J, Lambert-Hammill M, Patel S, Morrish Z, Lumb PJ, Lant AF. The apolipoprotein E2 allele modulates activity and maximal velocity of the sodium-lithium countertransporter. Am J Hypertens 2002; 15: 633–637
   Google Scholar
• Goulas A, Kosmidou M, Hatzitolios AI, Raikos N, Molyva D, Savopoulos C, Giannopoulos S, Fidani L. An association study of sodium-lithium countertransport activity with glutathione S transferase (GST) T1 and GST M1 null polymorphisms in Greek dyslipidaemic patients and controls. Clin Chem Lab Med 2008; 46: 306–310
   Google Scholar
• Kosmidou MS, Hatzitolios AI, Adamidou A, Giannopoulos S, Raikos N, Parharidis G, Milionis HJ. Effects of atorvastatin on red-blood cell Na+/Li+ countertransport in hyperlipidemic patients with and without hypertension. Am J Hypertens 2008; 21: 303–309
   PubMed Web of Science ®Google Scholar
• Mueller S, Riedel HD, Stremmel W. Direct evidence for catalase as the predominant H2O2-removing enzyme in human erythrocytes. Blood 1997; 90: 4973–4978
   PubMed Web of Science ®Google Scholar
• Forsberg L, Lyrenas L, de Faire U, Morgenstern R. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001; 30: 500–505
   PubMed Web of Science ®Google Scholar
• Ahn J, Nowell S, McCann SE, Yu J, Carter L, Lang NP, Kadlubar FF, Ratnasinghe LD, Ambrosone CB. Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev 2006; 15: 1217–1222
   PubMed Web of Science ®Google Scholar
• Bastaki M, Huen K, Manzanillo P, Chande N, Chen C, Balmes JR, Tager IB, Holland N. Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans. Pharmacogenet Genomics 2006; 16: 279–286
   PubMed Web of Science ®Google Scholar
• Perianayagam MC, Liangos O, Kolyada AY, Wald R, MacKinnon RW, Li L, Rao M, Balakrishnan VS, Bonventre JV, Pereira BJ, Jaber BL. NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure. J Am Soc Nephrol 2007; 18: 255–263
   PubMed Web of Science ®Google Scholar
• Nadif R, Mintz M, Jedlicka A, Bertrand J-P, Kleeberger SR, Kauffmann F. Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic Res 2005; 39: 1345–1350
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Zotova EV, Savostanov KV, Bursa TR, Galeev IV, Strokov IA, Nosikov VV. The 262T>C promoter polymorphism of the catalase gene is associated with diabetic neuropathy in type 1 diabetic Russian patients. Diabetes Metab 2006; 32: 63–68
   PubMed Web of Science ®Google Scholar
• Pask R, Cooper JD, Walker NM, Nutland S, Hutchings J, Dunger DB, Nejentsev S, Todd JA. No evidence for a major effect of two common polymorphisms of the catalase gene in type 1 diabetes susceptibility. Diabetes Metab Res Rev 2006; 22: 356–360
   PubMed Web of Science ®Google Scholar
• Gőth L, Lenkey A, Bigler WN. Blood catalase deficiency and diabetes in Hungary. Diabetes Care 2001; 10: 1839–1840
   Google Scholar
• Tarnai I, Csordas M, Sukei E, Shemirani AH, Kaplar M, G(th L. Effect of C111T polymorphism in exon 9 of the catalase gene on blood catalase activity in different types of diabetes mellitus. Free Radic Res 2007; 41: 806–811
   PubMed Web of Science ®Google Scholar
• Vaccaro O, Cuomo V, Trevisan M, Cirillo M, Panarelli W, Laurenzi M, Mancini M, Riccardi G; Gubbio Study Research Group. Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes. Int J Epidemiol 2005;34:1123–1128.
   Google Scholar
• Dos Santos KG, Canani LH, Gross JL, Tschiedel B, Pires Souto KE, Roisenberg I. The catalase -262C/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes. Dis Markers 2006; 22: 355–359
   PubMed Web of Science ®Google Scholar
• Szelestei T, Bahring S, Wagner Z, Aydin A, Molnár GA, Kocsis B, Nagy J, Wittmann I. Serum levels of L-arginine analogues and gluathione peroxidase and catalase gene variants in Type 2 diabetes mellitus patients. Diabet Med 2005; 22: 356–357
   Google Scholar
• Goulas A, Kosmidou M, Hatzitolios AI, Molyva D, Fidani L, Giannopoulos S, Mirtsou V. Glutathione S-transferase null and cholesteryl ester transfer protein TaqI B polymorphisms and lipid response to atorvastatin in Greek dyslipidaemic patients. Basic Clin Pharmacol Toxicol 2008; 102: 559–562
   PubMed Web of Science ®Google Scholar
• Canessa M, Adragna N, Solomon H, Connolly T, Tosteson D. Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 1980; 302: 772–776
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944–948
   PubMed Web of Science ®Google Scholar
• Keaney JF, Jr, Larson MG, Vasan RS. Obesity and systemic oxidative stress: clinical corelates of oxidative stress in the Framingham study. Arterioscler Thromb Vasc Biol 2003; 23: 434–439
   PubMed Web of Science ®Google Scholar
• D'souza A, Kurien BT, Rodgers A, Shenoi J, Kurono S, Matsumoto H, Hensley K, Nath SK, Scofield RH. Detection of catalase as a major protein target of the lipid peroxidation product 4-HNE and the lack of its genetic association as a risk factor in SLE. BMC 2008; Med Genet 9:62.
   Google Scholar
• Ho YS, Xiong Y, Ma W, Spector A, Ho DS. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 2004; 279: 32804–32812
   PubMed Web of Science ®Google Scholar